Valuation: ArcticZymes Technologies ASA

Market Cap 1.05B 112M 101M 92.95M 84.28M 156M 10.7B 160M 1.12B 443M 5.6B 422M 413M 17.62B P/E 2026 *
66.9x
P/E 2027 * 38.4x
Enterprise Value 768M 82.52M 73.84M 68.22M 61.86M 115M 7.85B 118M 820M 325M 4.11B 310M 303M 12.93B EV / Sales 2026 *
5.49x
EV / Sales 2027 * 4.62x
Free-Float
82.59%
Yield 2026 *
-
Yield 2027 * -
1 day+0.99%
1 week+4.86%
Current month+0.49%
1 month+0.49%
3 months+5.40%
6 months+3.54%
Current year-0.49%
1 week 18.5
Extreme 18.5
20.9
1 month 18.5
Extreme 18.5
21.1
Current year 18.3
Extreme 18.3
26.6
1 year 18.3
Extreme 18.3
30.5
3 years 12.34
Extreme 12.34
43.2
5 years 12.34
Extreme 12.34
100
10 years 3.5
Extreme 3.5
114.4
Manager TitleAgeSince
Chief Executive Officer - 17/09/2023
Director of Finance/CFO 51 30/09/2014
Chief Tech/Sci/R&D Officer 43 -
Director TitleAgeSince
Chairman 64 25/06/2024
Director/Board Member 62 25/06/2024
Director/Board Member - -
Date Insider Type Main position Quantity % Market Cap. Importance
14/08/25 Buy

Director

2,852 0.0056%
04/06/25 Buy

Chief Operating Officer

3,400 0.0067%
14/05/25 Exercice

Chief Operating Officer

15,000 0.0294%
Change 5-day change 1-year change 3-year change Capi.($)
+0.99%+4.86%-31.67%-19.92% 111M
+0.45%+1.76%+54.96%+118.11% 1,135B
+0.94%+4.20%+39.86%+75.69% 635B
+0.39%+0.46%+25.77%+97.40% 505B
+1.43%+4.56%+46.20%+66.91% 378B
-3.21%-3.66%+60.72%+35.68% 358B
-0.41%+2.23%+22.48%+48.54% 295B
+0.23%+3.28%+2.57%+21.89% 266B
+1.22%+2.81%+52.40%+63.37% 237B
+1.70%+1.60%+31.21%+102.44% 193B
Average +0.62%+1.82%+30.45%+61.01% 400.38B
Weighted average by Cap. +0.42%+1.63%+41.40%+81.03%

Financials

2026 *2027 *
Net sales 140M 15.04M 13.45M 12.43M 11.27M 20.92M 1.43B 21.44M 149M 59.21M 749M 56.42M 55.22M 2.36B 160M 17.2M 15.39M 14.22M 12.89M 23.93M 1.64B 24.52M 171M 67.73M 857M 64.54M 63.17M 2.7B
Net income 15.66M 1.68M 1.5M 1.39M 1.26M 2.34M 160M 2.4M 16.71M 6.62M 83.78M 6.31M 6.18M 263M 27.28M 2.93M 2.62M 2.42M 2.2M 4.08M 279M 4.18M 29.11M 11.54M 146M 10.99M 10.76M 459M
Net Debt -279M -29.91M -26.76M -24.73M -22.42M -41.61M -2.85B -42.65M -297M -118M -1.49B -112M -110M -4.69B -306M -32.89M -29.43M -27.19M -24.66M -45.76M -3.13B -46.9M -327M -130M -1.64B -123M -121M -5.15B
Projected Income Statement - Annual - ArcticZymes Technologies ASA
Logo ArcticZymes Technologies ASA
Arcticzymes Technologies ASA is a Norway-based holding company providing support functions to the ArcticZymes AS subsidiary including distribution, administration, finance, Information Technology (IT) and quality assurance. As a life science company, Arcticzymes Technologies ASA is focused on the development, manufacturing, and commercialization of novel and high-quality recombinant enzymes for use in molecular research, In Vitro Diagnostics (IVD) and biomanufacturing. Some of the key features of the Company’s enzymes include cold activeness and salt tolerance. The Company’s divided into two operating segments; Enzymes and Corporate. Arcticzymes established logistic hubs in the United States and the Netherlands to serve its customers more efficiently.
Employees
51
Date Price Change Volume
26/10/26 NOK 20.50 +0.99% 27,273
23/10/26 NOK 20.30 +2.27% 27,290
22/10/26 NOK 19.85 -1.73% 18,055
21/10/26 NOK 20.20 +7.16% 64,876
20/10/26 NOK 18.85 -0.26% 42,855
Trader
Investor
Global
Quality
ESG MSCI
-
MarketScreener Ratings - ArcticZymes Technologies ASA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
20.50NOK
Average target price
28.00NOK
Spread / Average Target
+36.59%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - ArcticZymes Technologies ASA